Medicare Payment Gap Filled In Landmark Deal

The US pharmaceutical industry has agreed to contribute US$80bn towards Medicare drug procurement packages for the elderly for the next 10 years. BMI believes that this commitment will reduce health payments for those with the highest healthcare needs and lowest ability to pay; it also gives the drugmakers a greater degree of leverage over any future policies within the US health financing system.

To read the full article, please choose one of the following options: